Integrated Core Strategies (US) LLC - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, 6, ...30, 31, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-05-28
4:22 pm
Purchase
2024-05-1713GAdaptive Biotechnologies Corporation
ADPT
Integrated Core Strategies (US) LLC7,750,133
5.300%
7,750,133increase
(New Position)
Filing
History
2024-05-20
4:14 pm
Purchase
2024-05-0813GAcelyrin, Inc.
SLRN
Integrated Core Strategies (US) LLC5,145,429
5.200%
233,184increase
(+4.75%)
Filing
History
2024-05-01
4:21 pm
Purchase
2024-04-2513GMyriad Genetics, Inc.
MYGN
Integrated Core Strategies (US) LLC4,544,150
5.000%
50,889increase
(+1.13%)
Filing
History
2024-04-25
4:18 pm
Purchase
2024-04-1713GMyriad Genetics, Inc.
MYGN
Integrated Core Strategies (US) LLC4,493,261
4.970%
931,924increase
(+26.17%)
Filing
History
2024-04-22
4:11 pm
Purchase
2024-04-1813GScreaming Eagle Acquisition Corp.
SCRM
Integrated Core Strategies (US) LLC1,460,000
8.500%
1,460,000increase
(New Position)
Filing
History
2024-04-19
4:12 pm
Purchase
2024-04-0913GAcelyrin, Inc.
SLRN
Integrated Core Strategies (US) LLC4,912,245
4.990%
4,912,245increase
(New Position)
Filing
History
2024-04-17
4:19 pm
Purchase
2024-04-0913GLivaNova PLC
LIVN
Integrated Core Strategies (US) LLC2,733,540
5.100%
2,733,540increase
(New Position)
Filing
History
2024-04-11
4:04 pm
Purchase
2024-04-0213GCOMPASS Pathways plc
CMPS
Integrated Core Strategies (US) LLC3,887,201
5.700%
3,887,201increase
(New Position)
Filing
History
2024-04-01
4:40 pm
Purchase
2024-03-2213GUtz Brands, Inc.
UTZ
Integrated Core Strategies (US) LLC4,189,067
5.100%
4,189,067increase
(New Position)
Filing
History
2024-03-25
4:36 pm
Purchase
2024-03-1913GMaxCyte, Inc.
MXCT
Integrated Core Strategies (US) LLC5,749,015
5.500%
736,732increase
(+14.70%)
Filing
History
2024-03-07
4:25 pm
Purchase
2024-02-2613GTPG Inc.
TPG
Integrated Core Strategies (US) LLC3,361,369
3.600%
3,361,369increase
(New Position)
Filing
History
2024-02-15
4:17 pm
Purchase
2024-02-0913GHelix Acquisition Corp. II
HLXB
Integrated Core Strategies (US) LLC1,100,000
5.800%
1,100,000increase
(New Position)
Filing
History
2024-02-14
4:08 pm
Sale
2023-12-3113GPlum Acquisition Corp. III
PLMJ
Integrated Core Strategies (US) LLC1,324,566
8.500%
-1,150,434decrease
(-46.48%)
Filing
History
2024-02-12
4:35 pm
Purchase
2023-12-3113GUnited Homes Group, Inc.
UHG
Integrated Core Strategies (US) LLC208,963
1.800%
208,963increase
(New Position)
Filing
History
2024-02-12
4:24 pm
Sale
2023-12-3113GFreeline Therapeutics Holdings plc
FRLN
Integrated Core Strategies (US) LLC0
0.000%
-5,555,085decrease
(Position Closed)
Filing
History
2024-02-09
4:11 pm
Purchase
2024-01-3113GCorbus Pharmaceuticals Holdings, Inc.
CRBP
Integrated Core Strategies (US) LLC419,707
4.100%
419,707increase
(New Position)
Filing
History
2024-02-08
4:43 pm
Purchase
2023-12-3113GVapotherm, Inc.
VAPO
Integrated Core Strategies (US) LLC490,044
7.800%
490,044increase
(New Position)
Filing
History
2024-02-08
4:36 pm
Purchase
2023-12-3113GSpyre Therapeutics, Inc.
SYRE
Integrated Core Strategies (US) LLC108,486
0.300%
108,486increase
(New Position)
Filing
History
2024-02-06
4:20 pm
Sale
2023-12-3113GCUTERA INC
CUTRQ
Integrated Core Strategies (US) LLC827,032
4.100%
-663,040decrease
(-44.50%)
Filing
History
2024-02-05
4:32 pm
Purchase
2023-12-3113GflyExclusive, Inc.
FLYX
Integrated Core Strategies (US) LLC37,500
0.200%
37,500increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, 6, ...30, 31, Next